Search Results for "Rna Interference Patents Dr Allen"

04:30 EDT 22nd May 2015 | BioPortfolio

Original Source: Benitec - RNAi patent update

22 March 2011, Melbourne, Australia: Benitec Limited (ASX: BLT), a world leader in expressed gene silencing for human therapeutics, today announced further positive progress in its fundamental Graham family patent applications exclusively licensed from CSIRO worldwide for human therapeutics. These patents cover silencing of genes using DNA-directed RNA interference (ddRNAi). Progress on these patent applications further strengthens Benitec’s position with regards to both its revenue opportunities...

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

UC Berkeley seeks interference on Broad's CRISPR patents

The University of California Berkeley filed a patent interference request with the U.S. Patent and Trademark Office (USPTO) related to 10 patents held by the Broad Institute of MIT and Harvard coverin...

Paul G. Allen Family Foundation awards $7.5 m to study brain cell growth and development

(Allen Institute) The Paul G. Allen Family Foundation announced today the award of Allen Distinguished Investigator grants to six groups of researchers with projects at the frontier of one of the most...

Allen Institute Debuts Neuron Periodic Table

Xconomy | With the Allen Cell Types Database, the Allen Institute for Brain Science aims to catalog and classify the types of neurons that fill the brain.

Inaugural Allen Distinguished Investigator Life Science Symposium

(Allen Institute) Researchers working to reanimate limbs using a brain-computer-spinal interface.Scientists exploring the genetics that make us human.An investigator searching for a new way to fight l...

Allen Institute Snags $100M to Create Cell Science Institute

Philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create the Allen Institute for Cell Science in Seattle.Read more about Allen Institute Snags $100M to Create Cel...

Atomic Hong–Ou–Mandel experiment

Two-particle interference is a fundamental feature of quantum mechanics, and is even less intuitive than wave–particle duality for a single particle. In this duality, classical concepts—wave or pa...

$100 Million Donated to Create Cell Science Institute for predictive models of cell behavior

Philanthropist and entrepreneur Paul G. Allen has commited $100 million to create the Allen Institute for Cell Science in Seattle. Founded to investigate and model the complex living machinery of...

Harnessing RNA Interference for Therapy The Silent Treatment

This Viewpoint discusses the role of RNA interference in therapy.

Matching PubMed Articles

Patents on Potential Drugs to Treat Alzheimer's Disease: Special Emphasis on Small Peptides.

The primary objective of this article is to review patents and the related scientific work on naturally occurring compounds, heterocyclic compounds and small peptides that are being explored for their...

The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.

Patents have long been considered essential incentives to foster innovation, particularly the development of new prescription drugs, due to the lengthy, costly, and risky nature of the research and de...

Stem Cell Patents after the America Invents Act.

Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to ...

The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design.

The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is provided by licensed organizations that have the permission to use the Allen Carr method. However, few d...

Quantifying innovation in surgery.

The objectives of this study were to assess the applicability of patents and publications as metrics of surgical technology and innovation; evaluate the historical relationship between patents and pub...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement